Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases “Several articles have remarked on the phenomena of molecular mimicry between SARS-CoV-2 and human proteins, and have postulated a connection between this mimicry and multi-organ disorders beyond the respiratory tract (5, 9, 10, 21–23). The reasoning is that immune response against the viral antigens following infection or vaccination can cross-react with human tissue antigens that share sequence homology with the virus, resulting in autoimmune reactivity, possibly followed by outright autoimmune disease. COMMENT: The vaccine can also cause autoimmunity, and there are treatments for the Sars-Cov-2 virus.
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases “Vaccine-induced autoimmunity from autoimmune cross-reactivity is associated with narcolepsy, Guillain-Barré syndrome, multiple sclerosis, demyelinating neuropathies, systemic lupus erythematosus, and postural orthostatic tachycardia syndrome in susceptible subgroups as reported by Segal and Shoenfeld. Due to the significant red flags for the potential cross-reactive interactions with the current COVID-19 pandemic, we studied the relationships between spike and nuclear proteins of SARS-CoV-2 and autoimmune target proteins. Due to the significant red flags for the potential cross-reactive interactions with the current COVID-19 pandemic, we studied the relationships between spike and nuclear proteins of SARS-CoV-2 and autoimmune target proteins. COMMENT: This study predated the paper above which also stated autoimmunity due to the COVID-19 vaccine.
The Vaccine Adverse Event Reporting System (VAERS) Results Form.pdf “Life Threatening and Death Results” COMMENT: Please take the time to read the reactions to the COVID-19 vaccine, you may be saving a life of injury or death.
[Comment] COVID‑19 vaccine safety “Due to the inadequate safety testing of several toxic stimuli in the past (including vaccines), it remains uncertain as to whether a number of diseases currently affecting humanity may be due in part to the actions of our predecessors passed on to us through transgenerational effects. It is uncertain as to whether any of the drugs, vaccines, foods or radiation exposures of our predecessors, which were not tested for transgenerational effects, are adversely affecting human life at present. Of note, the question remains whether humanity is currently willing to pass on potential devastating diseases to future generations due to the present need for the speedy development of a vaccine, bypassing adequate long-term and transgenerational safety testing.
There are also ethical issues of concern associated with accelerated vaccine development, particularly with the drastic reduction in time devoted to clinical trial phases II and III. The main target population for a vaccine is the most vulnerable demographically: the elderly with high comorbidities and dysfunctional immune systems. Yet, the test demographic population being used for the initial clinical trials is the relatively young and healthy population (as discussed below). This leads to uncertainty regarding the efficacy of the trial, raising issues as to how the results from a young healthy population can be extrapolated to an elderly and vulnerable population. Additionally, in myriad cultures, it is the elderly who sacrifice for the benefit of the young. This tradition is being inverted in the present accelerated testing regimen.
In the present political environment, there is the potential that the majority of the population could be required to be vaccinated, even those demographics that were not vulnerable to the severe effects of COVID-19, and particularly those in the youngest demographic. The potential adverse consequences of such a mass inoculation with a vaccine not adequately tested for mid- and long-term adverse effects could be substantial. between spike and nuclear proteins of SARS-CoV-2 and autoimmune target proteins. Comment: These statements are more than enough to do the research regarding important decisions for your family.
Disseminated varicella zoster virus infection after vaccination with a live attenuated vaccine “The patient had a past history of hypertension, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease and atrial flutter. Successful cardiac ablation had been performed 2 weeks before the onset of the rash. He also had rheumatoid arthritis, treated with methotrexate, 2.5 mg/d (6 d per week) for 3 years, hydroxychloroquine, 200 mg/d and prednisone, 10 mg/d. … Live virus vaccines are typically contraindicated in immunocompromised people. However, in light of the high burden of reactivation and complications of zoster in immunocompromised hosts, before 2018, vaccination of immunocompromised people with live zoster vaccine could be considered under certain circumstances. COMMENT: Here is another vaccine that should not be given to immunocompromised people.